2016 U.K. Hospital Hemostasis Diagnostics Market
This new report from VPGMarketResearch contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including:
- Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Volume and sales forecasts for 40 coagulation procedures performed in UK hospitals, including typical coagulation daily work loads.
- Review of current instrumentation technologies, and a feature comparison of leading analyzers.
- Reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of coagulation technologies and their potential market applications.
- Major opportunities for coagulation instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
NASBA
SDA
3 SR
HPA
Two-Tiered System
LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
JAPAN
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Dot Immunobinding Assays
Capillary Immunoassays
Enzyme Amplification
Electrochemical Immunoassay
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
NASBA
SDA
3 SR
HPA
Two-Tiered System
LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
JAPAN
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
LIST OF TABLES
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table : Japan, Hospital Coagulation Diagnostics Market By Market Segment and Product Category
Japan, Hospital Laboratories Performing Coagulation Tests By Bed Size
Japan, Hospital Laboratories Average Daily Test Volume
Japan, Hospital Laboratories Coagulation Test Volume by Assay
Japan, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
Japan, Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
Japan, Total Coagulation Diagnostics Market By Product Category
Japan, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table : Japan, Hospital Coagulation Diagnostics Market By Market Segment and Product Category
Japan, Hospital Laboratories Performing Coagulation Tests By Bed Size
Japan, Hospital Laboratories Average Daily Test Volume
Japan, Hospital Laboratories Coagulation Test Volume by Assay
Japan, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
Japan, Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
Japan, Total Coagulation Diagnostics Market By Product Category
Japan, Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares